Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity

Cancer Causes and Control

Volumn 20, Issue 10, 2009, Pages 1915-1926

  Nock, Nora L ^a,b   Bock, Cathryn ^c   Neslund Dudas, Christine ^d   Beebe Dimmer, Jennifer ^c   Rundle, Andrew ^e   Tang, Deliang ^e   Jankowski, Michelle ^d   Rybicki, Benjamin A ^d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e Howard Hughes Medical Institute   (United States)

Author keywords

Biochemical recurrence; GSTM1; GSTP1; GSTT1; Prostate cancer

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; ISOLEUCINE; PROSTATE SPECIFIC ANTIGEN; VALINE;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; UNITED STATES;

AFRICAN AMERICANS; AGED; CARCINOMA; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 71349088365     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9385-0     Document Type: Article

References (24)

1. A Jemal R Siegel E Ward, et al.. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 10.3322/CA.2007.0010 18287387
2. I Thompson C Tangen A Tolcher E Crawford M Eisenberger C Moinpour 2001 Association of African-American ethnic background with survival in men with metastatic prostate cancer J Natl Cancer Inst 93 219 225 10.1093/jnci/93.3.219 10.1093/jnci/93.3.219 1:STN:280:DC%2BD3M7ot1Kgsg%3D%3D 11158191
3. GD Grossfeld DM Latini DP Lubeck SS Mehta PR Carroll 2003 Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer J Urol 169 157 163 10.1016/S0022-5347(05)64058-X 10.1016/S0022-5347(05) 64058-X 12478126
4. AV D'Amico K Cote M Loffredo AA Renshaw MH Chen 2003 Pretreatment predictors of time to cancer specific death after prostate specific antigen failure J Urol 169 1320 1324 10.1097/01.ju.0000049200.30192.d1 10.1097/01.ju.0000049200.30192.d1 12629352 (Pubitemid 36323776)
5. B Ercole SR Marietti J Fine PC Albertsen 2008 Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era J Urol 180 1336 1339 10.1016/j.juro.2008.06.027 10.1016/j.juro.2008.06.027 18707696
6. HM Wood AM Reuther TD Gilligan PA Kupelian CS Modlin Jr EA Klein 2007 Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration J Urol 178 1271 1276 10.1016/j.juro.2007.05.127 10.1016/j.juro.2007.05.127 17698101 (Pubitemid 47368391)
7. JD Hayes JU Flanagan IR Jowsey 2005 Glutathione transferases Annu Rev Pharmacol Toxicol 45 51 88 10.1146/annurev.pharmtox.45.120403.095857 10.1146/annurev.pharmtox.45.120403.095857 1:CAS:528:DC%2BD2MXisVWjtrk%3D 15822171 (Pubitemid 40261798)
8. L Flowers WF Bleczinski ME Burczynski RG Harvey TM Penning 1996 Disposition and biological activity of benzo[a]pyrene-7, 8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase Biochemistry 35 13664 13672 10.1021/bi961077w 10.1021/bi961077w 1:CAS:528:DyaK28XlvFequrk%3D 8885846 (Pubitemid 26359179)
9. JD Yager JG Liehr 1996 Molecular mechanisms of estrogen carcinogenesis Annu Rev Pharmacol Toxicol 36 203 232 10.1146/annurev.pa.36.040196.001223 10.1146/annurev.pa.36.040196.001223 1:CAS:528:DyaK28Xis1ertbw%3D 8725388
10. OA Di Paolo CH Teitel S Nowell BF Coles FF Kadlubar 2005 Expression of cytochromes P450 and glutathione S-transferases in human prostate, and the potential for activation of heterocyclic amine carcinogens via acetyl-coA-, PAPS- and ATP-dependent pathways Int J Cancer 117 8 13 10.1002/ijc.21152 10.1002/ijc.21152 1:CAS:528:DC%2BD2MXhtVaht7rO 15880531 (Pubitemid 41262754)
11. J Elek KH Park R Narayanan 2000 Microarray-based expression profiling in prostate tumors In Vivo 14 173 182 1:CAS:528:DC%2BD3cXisFOjsrk%3D 10757075
12. C Ntais A Polycarpou JP Ioannidis 2005 Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis Cancer Epidemiol Biomarkers Prev 14 176 181 1:CAS:528:DC%2BD2MXmsVOmsQ%3D%3D 15668493
13. NL Nock D Tang A Rundle, et al.. 2007 Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race Cancer Epidemiol Biomarkers Prev 16 1236 1245 10.1158/1055-9965.EPI-06-0736 10.1158/1055-9965.EPI-06-0736 1:CAS:528:DC%2BD2sXmtVKntLk%3D 17548691 (Pubitemid 46984965)
14. I Agalliu DW Lin CA Salinas Z Feng JL Stanford 2006 Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis Prostate 66 1535 1541 10.1002/pros.20491 10.1002/pros.20491 1:CAS:528: DC%2BD28XhtFWks7zE 16921513 (Pubitemid 44465818)
15. BA Rybicki C Nesland-Dudas NL Nock, et al.. 2006 Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism Cancer Detect Prev 30 412 422 10.1016/j.cdp.2006.09.004 10.1016/j.cdp.2006.09.004 1:CAS:528: DC%2BD2sXkslGrtg%3D%3D 17067754 (Pubitemid 44750413)
16. M Arand R Muhlbauer J Hengstler E Jager J Fuchs L Winkler 1996 A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms Anal Biochem 236 184 186 10.1006/abio.1996.0153 10.1006/abio.1996.0153 1:CAS:528:DyaK28XhvFGns70%3D 8619490 (Pubitemid 26100747)
17. JW Kim CG Lee YG Park, et al.. 2000 Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma Cancer 88 2082 2091 10.1002/(SICI)1097- 0142(20000501)88:9<2082::AID-CNCR14>3.0.CO;2-D 10.1002/(SICI)1097- 0142(20000501)88:9<2082::AID-CNCR14>3.0.CO;2-D 1:CAS:528: DC%2BD3cXjtF2mu74%3D 10813720 (Pubitemid 30233210)
18. SJ Freedland ME Sutter F Dorey WJ Aronson 2003 Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen Urology 61 365 369 10.1016/S0090-4295(02)02268-9 10.1016/S0090-4295(02)02268-9 12597949 (Pubitemid 36206534)
19. PA Kupelian M Elshaikh CA Reddy C Zippe EA Klein 2002 Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above Cancer 95 2302 2307 10.1002/cncr.10977 10.1002/cncr.10977 12436435 (Pubitemid 35351135)
20. CJ Hoggart EJ Parra MD Shriver, et al.. 2003 Control of confounding of genetic associations in stratified populations Am J Hum Genet 72 1492 1504 10.1086/375613 10.1086/375613 1:CAS:528:DC%2BD3sXktlyit7c%3D 12817591 (Pubitemid 36628388)
21. BA Rybicki C Neslund-Dudas CH Bock, et al.. 2008 Polycyclic aromatic hydrocarbon-DNA adducts in prostate and biochemical recurrence after prostatectomy Clin Cancer Res 14 750 757 10.1158/1078-0432.CCR-07-0986 10.1158/1078-0432.CCR-07-0986 1:CAS:528:DC%2BD1cXhsFyktrY%3D 18245535 (Pubitemid 351231156)
22. I Meiers JH Shanks DG Bostwick 2007 Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007 Pathology 39 299 304 10.1080/00313020701329906 10.1080/00313020701329906 1:CAS:528: DC%2BD2sXmt1ant70%3D 17558856 (Pubitemid 46897603)
23. J Ellinger PJ Bastian T Jurgan, et al.. 2008 CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer Urology 71 161 167 10.1016/j.urology.2007.09.056 10.1016/j.urology.2007.09.056 18242387 (Pubitemid 351173282)
24. I Agalliu WJ Langeberg JW Lampe CA Salinas JL Stanford 2006 Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men Prostate 66 146 166 10.1002/pros.20305 10.1002/pros.20305 1:CAS:528:DC%2BD28Xhs1KmsL8%3D 16173036 (Pubitemid 43191236)